Aclaris Therapeutics, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
ACRS on Nasdaq
Industry
Pharmaceutical Preparations
Location
701 Lee Road, Suite 103, Wayne, PA

Insiders trading volume in the past year

Aclaris Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Braden Michael Leonard 10%+ Owner $17.7M +$5.59M +46.1% Aug 2, 2024
Neal Walker INTERIM CEO, Director $5.5M Dec 4, 2024
Anand Mehra Director $1.6M +$1.5M +1463% Nov 19, 2024
Joseph Monahan Chief Scientific Officer $647K Dec 10, 2024
Andrew N. Schiff Director $564K Jun 6, 2024
Hugh M. Davis President and COO, Director $435K Dec 2, 2024
Frank Ruffo Chief Financial Officer $212K Mar 10, 2022
James Loerop Chief Business Officer $196K Feb 1, 2024
Kamil Ali-Jackson Chief Legal Officer $168K Jan 3, 2022
David N. Gordon Chief Medical Officer $155K Jul 13, 2021
Douglas J. Manion Pres and CEO, Director $129K Jan 1, 2024
Christopher P. Molineaux Director $71.9K Jun 6, 2024
Gail Cawkwell Chief Medical Officer $57.3K Jul 1, 2023
Andrew Kenneth William Powell Director $42.2K +$18K +73.9% Jun 1, 2024
William D. Humphries Director $41.1K Jun 6, 2024
Bryan M. Reasons Director $36.2K Jun 1, 2024
Kevin Balthaser Chief Financial Officer $29.1K Sep 1, 2024
Maxine Gowen Director $26.3K Jun 6, 2024
Vincent Milano Director $20.7K Jun 6, 2024
Foresite Capital Management III, LLC 10%+ Owner $8.69K Nov 1, 2021
Biosion, Inc. 10%+ Owner Nov 18, 2024

Recent Insider Transactions by Companies or Individuals for Aclaris Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.